New Products & Services

July 1, 2006

Somerville, NJ-A new mid-urethral sling device from the Women's Heath & Urology division of Ethicon, Inc., has received 510(k) approval from the FDA for use beginning in autumn 2006. The Gynecare TVT SECUR System is a polypropylene mesh tape that is inserted through the vagina and positioned under the urethra to form a supportive scaffold. It prevents urine loss by maintaining the seal in the bladder neck during movement. No incisions are required, and the procedure can be conducted under local anesthesia, minimizing post-surgical pain and complications. The device is contraindicated for women who are or who intend to become pregnant and those who are on anticoagulant therapy.

Somerville, NJ-A new mid-urethral sling device from the Women's Heath & Urology division of Ethicon, Inc., has received 510(k) approval from the FDA for use beginning in autumn 2006. The Gynecare TVT SECUR System is a polypropylene mesh tape that is inserted through the vagina and positioned under the urethra to form a supportive scaffold. It prevents urine loss by maintaining the seal in the bladder neck during movement. No incisions are required, and the procedure can be conducted under local anesthesia, minimizing post-surgical pain and complications. The device is contraindicated for women who are or who intend to become pregnant and those who are on anticoagulant therapy.

For more information, visit http://www.gynecare.com/

New graft is designed to correct Peyronie's

For more information, visit http://www.cookmedical.com/

Plug-and-play BPH laser system is completely mobile

For more information, visit http://www.laserscope.com/

Injectable implant gains approval to treat female SUI

Natick, MA and San Mateo, CA-The FDA has approved the Coaptite Injectable Implant from Boston Scientific Corp. and BioForm Medical, Inc. for the treatment of female stress urinary incontinence. The implant combines calcium hydroxylapatite particles-biocompatible components found in bone and teeth-and sodium carboxymethylcellulose carrier gel to form a scaffold that promotes tissue infiltration. In clinical trials, fewer injections and less material volume were required than with other bulking agents, and the implant demonstrated the durability of a synthetic agent, according to the companies.

For more information, visit http://www.bostonscientific.com/